ProCE Banner Series

Updates in Targeting IDH1 in Relapsed/Refractory AML

Join Dr Jorge Cortes for a review of the emerging data on the use of targeted therapy for patients with relapsed/refractory acute myeloid leukemia with IDH1 mutations including data presented at EHA 2024! This presentation will discuss new data sets, including information on treatment sequencing and difficult-to-treat populations, and their potential impacts on clinical decision-making. An interactive Q&A with Dr Cortes will follow the presentation.

Key Takeaways:

  • Review updated data for patients with R/R AML with IDH1 mutations
  • Understand the management of R/R AML with IDH1 mutations

All Events

Updates in Targeting IDH1 in Relapsed/Refractory AML

Past Events

August

21

2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Jorge E. Cortes, MD

Professor of Medicine
Director, Georgia Cancer Center
Cecil F. Whitaker Jr., GRA Eminent Scholar Chair in Cancer
Augusta University
Augusta, Georgia